中华检验医学杂志
中華檢驗醫學雜誌
중화검험의학잡지
CHINESE JOURNAL OF LABORATORY MEDICINE
2014年
6期
415-419
,共5页
肾功能不全,慢性%肌酸酐%胱抑素C%预后
腎功能不全,慢性%肌痠酐%胱抑素C%預後
신공능불전,만성%기산항%광억소C%예후
Renal insufficiency,chronic%Creatinine%Cystatin C%Prognosis
慢性肾脏病患者肾功能下降程度与其死亡、心血管事件和进展至终末期肾脏病的风险密切相关,目前临床常用基于血肌酐或胱抑素C的肾小球滤过率估算方程对肾功能进行评估。虽然不断改进基于肌酐的GFR评估公式可以更准确地评估肾功能,但肌酐在估算GFR方面存在的先天缺陷是难以克服的。大量研究发现,以胱抑素C为基础的肾小球滤过率估算方程相对于以血肌酐为基础的肾小球滤过率估算方程在评估慢性肾脏病预后方面具有显著差异,前者特异性更好,可以减少对于低危患者的不必要的肾科就诊和检查,又可以使高危患者得到更准确地辨认从而及时就诊干预。本文着重介绍肌酐和胱抑素C在慢性肾脏病诊断及预后风险评估方面的差异。(中华检验医学杂志,2014,37:415-419)
慢性腎髒病患者腎功能下降程度與其死亡、心血管事件和進展至終末期腎髒病的風險密切相關,目前臨床常用基于血肌酐或胱抑素C的腎小毬濾過率估算方程對腎功能進行評估。雖然不斷改進基于肌酐的GFR評估公式可以更準確地評估腎功能,但肌酐在估算GFR方麵存在的先天缺陷是難以剋服的。大量研究髮現,以胱抑素C為基礎的腎小毬濾過率估算方程相對于以血肌酐為基礎的腎小毬濾過率估算方程在評估慢性腎髒病預後方麵具有顯著差異,前者特異性更好,可以減少對于低危患者的不必要的腎科就診和檢查,又可以使高危患者得到更準確地辨認從而及時就診榦預。本文著重介紹肌酐和胱抑素C在慢性腎髒病診斷及預後風險評估方麵的差異。(中華檢驗醫學雜誌,2014,37:415-419)
만성신장병환자신공능하강정도여기사망、심혈관사건화진전지종말기신장병적풍험밀절상관,목전림상상용기우혈기항혹광억소C적신소구려과솔고산방정대신공능진행평고。수연불단개진기우기항적GFR평고공식가이경준학지평고신공능,단기항재고산GFR방면존재적선천결함시난이극복적。대량연구발현,이광억소C위기출적신소구려과솔고산방정상대우이혈기항위기출적신소구려과솔고산방정재평고만성신장병예후방면구유현저차이,전자특이성경호,가이감소대우저위환자적불필요적신과취진화검사,우가이사고위환자득도경준학지변인종이급시취진간예。본문착중개소기항화광억소C재만성신장병진단급예후풍험평고방면적차이。(중화검험의학잡지,2014,37:415-419)
Renal function is closely associated with the risk of mortality ,cardiovascular events ,and progression to end stage of renal disease for patients with chronic kidney disease ( CKD ).Equations for estimated glomerular filtration rate ( GFR) based on serum creatinine or Cystatin C are frequently used in clinical evaluation of renal function.Although renal function can be more accurately assessed due to improvement in equations for estimated GFR ,it is difficult to overcome the inherent defect of creatinine based GFR estimation.Abundant ,evidence showed that Cystatin C based GFR estimation presented higher accuracy of prognosis assessment in CKD patients than creatinine based GFR estimation ,thus reduce the unnecessary nephrologist referral and measurements for low risk patients ,and also guarantee the timely recognization and intervention for high risk patients.This article deeply reviewed the role of serum creatinine or Cystatin C played in CKD diagnosis and prognosis assessment.